About ZoBio
ZoBio is a company based in Leiden (Netherlands) founded in 2004 was acquired by Oncodesign Services in January 2024. ZoBio offers products and services including Drug Discovery Services and Biophysical Assays. ZoBio operates in a competitive market with competitors including Slingshot Bioscience, StemoniX, Magnitude Biosciences, InterAx Biotech and Signal Pharmaceuticals, among others.
- Headquarter Leiden, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zobio Bv
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$277.64 K (USD), Grant
Mar 01, 2016
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Acquired by
Oncodesign Services
(Jan 23, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ZoBio
ZoBio offers a comprehensive portfolio of products and services, including Drug Discovery Services and Biophysical Assays.
Comprehensive services for identifying molecules in drug development
Tools for biochemical analysis in protein-based drug discovery
Funding Insights of ZoBio
Investors in ZoBio
ZoBio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Oncodesign Services.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
CRO focused on oncology drugs discovery, bioanalysis, and preclinical services
|
Locked | Locked | Locked |
Investor details for ZoBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ZoBio
Investment portfolio details for ZoBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ZoBio
Detailed financials for ZoBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zobio Comparisons
Peer comparison for ZoBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ZoBio
ZoBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Slingshot Bioscience, StemoniX, Magnitude Biosciences, InterAx Biotech and Signal Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation synthetic cells are developed for diagnostics and therapeutics.
|
|
| Locked | Locked | Locked |
Developing a commercial scale printer for the high-volume growth and differentiation of stem cells and stem cell products.
|
|
| Locked | Locked | Locked |
Cell-free in vitro assays are supplied to drug discovery firms.
|
|
| Locked | Locked | Locked |
Mutated arrestins are employed as biosensors for GPCR drug discovery.
|
|
| Locked | Locked | Locked |
Small molecule drugs regulating disease-associated genes are developed.
|
|
| Locked | Locked | Locked |
Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines.
|
Detailed competitors of ZoBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zobio
Complete news archive for ZoBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZoBio
ZoBio was founded in 2004 and raised its 1st funding round 12 years after it was founded.
ZoBio is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
ZoBio offers fragment-based drug discovery services for the pharmaceutical and biotechnology industries. They have developed a proprietary Target Immobilized NMR Screening (TINS) technology. They have also developed drug discovery platforms offering protein production, HIT discovery, and structural biology.
ZoBio's top competitors include Magnitude Biosciences, Slingshot Bioscience and StemoniX.
ZoBio offers Drug Discovery Services and Biophysical Assays.
ZoBio has 2 investors. Key investors include European Union, and Oncodesign Services.